Cargando…

Association of Race and Major Adverse Cardiac Events (MACE): The Atherosclerosis Risk in Communities (ARIC) Cohort

BACKGROUND AND AIMS: To evaluate the association of self-reported race with major adverse cardiac events (MACE) and modification of this association by paraoxonase gene (PON1, PON2, and PON3) single nucleotide polymorphisms (SNPs). METHODS: Included in this longitudinal study were 12,770 black or wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franey, Ericha G, Kritz-Silverstein, Donna, Richard, Erin L, Alcaraz, John E, Nievergelt, Caroline M, Shaffer, Richard A, Bhatnagar, Vibha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114773/ https://www.ncbi.nlm.nih.gov/pubmed/32280543 http://dx.doi.org/10.1155/2020/7417242

Ejemplares similares

MACE in the Race: A Canadian Perspective on Major Adverse Cardiac Events (MACE) During Running
por: Abrahim, Mohammed
Publicado: (2022)

Optimism and Mortality in Older Men and Women: The Rancho Bernardo Study
por: Anthony, Ericha G., et al.
Publicado: (2016)

Current Progress of Studies of Coronary CT for Risk Prediction of Major Adverse Cardiovascular Event (MACE)
por: Zheng, Jianan, et al.
Publicado: (2021)

The Relationship Between Cardiac Troponin in People Hospitalised for Exacerbation of COPD and Major Adverse Cardiac Events (MACE) and COPD Readmissions
por: Kallis, Constantinos, et al.
Publicado: (2023)

Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study
por: Farshidi, Hossein, et al.
Publicado: (2018)

A prediction model for major adverse cardiovascular events (MACE) in patients with coronavirus disease 2019 (COVID-19)
por: Huang, Dong, et al.
Publicado: (2022)

Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights
por: Marsal, Josep Ramon, et al.
Publicado: (2022)

Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE)
por: Chen, Dongqing, et al.
Publicado: (2023)

Patient perspective of tardive dyskinesia: results from a social media listening study
por: Farrar, Mallory, et al.
Publicado: (2021)

Circulating Magnesium and Risk of Major Adverse Cardiac Events among Patients with Atrial Fibrillation in the ARIC Cohort
por: Li, Linzi, et al.
Publicado: (2023)

Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin
por: Sardu, Celestino, et al.
Publicado: (2019)

Major Adverse Cardiovascular Events (MACE) in COVID-19 Infection and the Role of Cardiac Biomarkers: A Systematic Literature Review
por: Mahendran, S., et al.
Publicado: (2021)

Sphingolipids and physical function in the Atherosclerosis Risk in Communities (ARIC) study
por: Li, Danni, et al.
Publicado: (2021)

Retrospective Study of Appropriate Primary Prevention in Postmenopausal Women Presenting with a Major Adverse Cardiovascular Endpoint (MACE)
por: Cieri-Hutcherson, Nicole E., et al.
Publicado: (2022)

Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes
por: Xie, Gaoqiang, et al.
Publicado: (2017)

331 A Machine Learning-based Pharmacogenomic Association Study of Major Adverse Cardiovascular Events (MACEs) in Caribbean Hispanic Patients on Clopidogrel
por: Arroyo, Luis A. Rosario, et al.
Publicado: (2022)

Obstructive airway disease and edentulism in the atherosclerosis risk in communities (ARIC) study
por: Offenbacher, Steven, et al.
Publicado: (2012)

Increases in Biomarkers of Hyperglycemia With Age in the Atherosclerosis Risk in Communities (ARIC) Study
por: Warren, Bethany, et al.
Publicado: (2017)

Liver Enzymes and Risk of Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
por: Ruban, Angela, et al.
Publicado: (2020)

Diabetes and the risk of hospitalisation for infection: the Atherosclerosis Risk in Communities (ARIC) study
por: Fang, Michael, et al.
Publicado: (2021)

Lung Function and Dementia Risk in the Atherosclerosis Risk in Communities (ARIC) Study
por: Shrestha, Srishti, et al.
Publicado: (2021)

Rhinitis induced to mace
por: Sanchez Moreno, Gema Vanesa, et al.
Publicado: (2011)

MIDLIFE PHYSICAL ACTIVITY AND HEARING IMPAIRMENT IN LATE LIFE: ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY
por: Martinez-Amezcua, Pablo, et al.
Publicado: (2022)

Reduction of Major Adverse Cardiovascular Events (MACE) after Bariatric Surgery in Patients with Obesity and Cardiovascular Diseases: A Systematic Review and Meta-Analysis
por: Sutanto, Andryanto, et al.
Publicado: (2021)

4423 Impact of Gender on High On-Treatment Platelet Reactivity (HPR) and Major Adverse Cardiovascular Events (MACEs) in Caribbean Hispanic patients using Clopidogrel
por: Nunez Medina, Hector Jose, et al.
Publicado: (2020)

Comparison of m-mode echocardiographic left ventricular mass measured using digital and strip chart readings: The Atherosclerosis Risk in Communities (ARIC) study
por: Arnett, Donna K, et al.
Publicado: (2003)

Dipeptidyl Peptidase IV and Incident Diabetes: The Atherosclerosis Risk in Communities (ARIC) study
por: Luft, Vivian C., et al.
Publicado: (2010)

Comparative Prognostic Performance of Definitions of Prediabetes in the Atherosclerosis Risk in Communities (ARIC) Study
por: Warren, Bethany, et al.
Publicado: (2016)

Galectin‐3 and venous thromboembolism incidence: the Atherosclerosis Risk in Communities (ARIC) Study
por: Fashanu, Oluwaseun E., et al.
Publicado: (2017)

Methods to estimate underlying blood pressure: The Atherosclerosis Risk in Communities (ARIC) Study
por: Balakrishnan, Poojitha, et al.
Publicado: (2017)

Mitochondrial DNA copy number and diabetes: the Atherosclerosis Risk in Communities (ARIC) study
por: DeBarmore, Bailey, et al.
Publicado: (2020)

Development and Characterization of Proteomic Aging Clocks in the Atherosclerosis Risk in Communities (ARIC) Study
por: Wang, Shuo, et al.
Publicado: (2023)

Risk prediction model for major adverse cardiovascular events (MACE) during hospitalization in patients with coronary heart disease based on myocardial energy metabolic substrate
por: Na, Li, et al.
Publicado: (2023)

Association of a Fasting Glucose Genetic Risk Score With Subclinical Atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study
por: Rasmussen-Torvik, Laura J., et al.
Publicado: (2011)

Leisure-time physical activity volume, intensity, and duration from mid- to late-life in U.S. subpopulations by race and sex. The Atherosclerosis Risk In Communities (ARIC) Study
por: Kats, Dmitry, et al.
Publicado: (2020)

Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study
por: Reyes, Luis Felipe, et al.
Publicado: (2023)

Bringing Critical Race Praxis Into the Study of Electrophysiological Substrate of Sudden Cardiac Death: The ARIC Study
por: Jensen, Kelly, et al.
Publicado: (2020)

Stroke Mortality, Clinical Presentation and Day of Arrival: The Atherosclerosis Risk in Communities (ARIC) Study
por: O'Brien, Emily C., et al.
Publicado: (2011)

Lipid-lowering pharmacotherapy and socioeconomic status: atherosclerosis risk in communities (ARIC) surveillance study
por: Kitzmiller, Joseph P, et al.
Publicado: (2013)

Metabolomics and Incidence of Atrial Fibrillation in African Americans: The Atherosclerosis Risk in Communities (ARIC) Study
por: Alonso, Alvaro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s800l2anqdnd25su17d1h713kc